Skip to main content
. 2022 May 19;14(10):2500. doi: 10.3390/cancers14102500

Table 1.

Ovarian damage risk with chemotherapeutic agents.

Damage Risk Cancer Treatment
High risk CMF
Cyclophosphamide
Melphalan
Busulfan
Intermediate risk Cisplatin
Carboplatin
Oxaliplatin
Doxorubicin
Low/very low CHOP
Vinblastine
Vincristine
Methotrexate
5-fluorouracil

Notes: CHOP, cyclophosphamide/doxorubicin/vincristine/prednisone; CMF, ciclofosfamide, methotrexate e 5-fluorouracile.